Skip to main content
. 2023 Aug 15;330(7):603–614. doi: 10.1001/jama.2023.12357

Table 1. Baseline Characteristics for Pregnant Individuals.

Magnesium sulfate (n = 729)a Placebo (n = 704)a
Participant age, mean (SD), y 30.5 (6.2) 30.6 (6.9)
Parity
0 359 (49.2) 379 (53.8)
≥1 370 (50.8) 325 (46.2)
Race and ethnicityb
Aboriginal or Torres Strait Islander 22 (3.0) 24 (3.4)
Asian 127 (17.4) 110 (15.6)
Māori 43 (5.9) 39 (5.5)
Pacific 30 (4.1) 31 (4.4)
White 486 (66.7) 480 (68.2)
Otherc 21 (2.9) 20 (2.8)
Body mass index, median (IQR)d 25.0 (22.1-30.1) 25.3 (22.2-29.8)
Gestational age at entry, mean (SD), wk 32.1 (1.1) 32.1 (1.1)
30-<32 323 (44.3) 308 (43.8)
32-<34 406 (55.7) 396 (56.3)
Socioeconomic statuse
Most disadvantaged 192 (26.3) 185 (26.3)
Disadvantaged 108 (14.8) 116 (16.5)
Middle 171 (23.5) 137 (19.5)
Advantaged 140 (19.2) 123 (17.5)
Most advantaged 118 (16.2) 143 (20.3)
Infant sex, No./total (%)f
Female 385/858 (44.9) 349/821 (42.5)
Male 473/858 (55.1) 472/821 (57.5)
Twin pregnancy 130 (17.8) 120 (17.0)
Prior event
Preterm birth (<37 weeks’ gestation) 149 (20.4) 128 (18.2)
Perinatal death (≥20 weeks’ gestation) 31 (4.3) 30 (4.3)
Prenatal use of corticosteroids 709 (97.3) 682 (96.9)
Reason at risk for preterm birth
Preterm labor 207 (28.4) 182 (25.9)
Preterm and prelabor rupture of membranes 206 (28.3) 183 (26.0)
Fetal compromise 129 (17.7) 129 (18.3)
Preeclampsia 65 (8.9) 81 (11.5)
Antepartum hemorrhage 72 (9.9) 67 (9.5)
Unspecified 50 (6.9) 62 (8.8)
a

Data are expressed as No. (%) unless otherwise indicated.

b

Race and ethnicity were self-reported by the pregnant individual at study entry.

c

Included African, Middle Eastern, and South American.

d

Calculated as weight in kilograms divided by height in meters squared.

e

Derived from the Australian Socio-Economic Indexes for Areas29 and the New Zealand Socioeconomic Deprivation Profile.30

f

The denominators (858 + 821) equal the 1679 infants who were included in the randomization of the pregnant individuals.